000 01531 a2200421 4500
005 20250513145043.0
264 0 _c19980709
008 199807s 0 0 eng d
022 _a0007-0920
024 7 _a10.1038/bjc.1998.233
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAdams, G P
245 0 0 _aProlonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2/neu.
_h[electronic resource]
260 _bBritish journal of cancer
_cMay 1998
300 _a1405-12 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aAntibody Affinity
650 0 4 _aAntigens, Neoplasm
_ximmunology
650 0 4 _aDimerization
650 0 4 _aHumans
650 0 4 _aImmunoglobulin Heavy Chains
_xadministration & dosage
650 0 4 _aImmunoglobulin Light Chains
_xadministration & dosage
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aImmunotoxins
_xadministration & dosage
650 0 4 _aMice
650 0 4 _aMice, SCID
650 0 4 _aReceptor, ErbB-2
_ximmunology
650 0 4 _aTissue Distribution
700 1 _aSchier, R
700 1 _aMcCall, A M
700 1 _aCrawford, R S
700 1 _aWolf, E J
700 1 _aWeiner, L M
700 1 _aMarks, J D
773 0 _tBritish journal of cancer
_gvol. 77
_gno. 9
_gp. 1405-12
856 4 0 _uhttps://doi.org/10.1038/bjc.1998.233
_zAvailable from publisher's website
999 _c9618880
_d9618880